Joost Breeksema - The Interdisciplinary Conference on Psychedelic Research
Release Date: 02/04/2020
Psychedelics Today
From the Rave Scene to Psychedelic Therapy In this episode, Kyle Buller speaks with Matt Xavier, DJ, therapist, and author. The conversation took place live at Psychedelic Science. Matt recalls his early years in the rave culture of 1990s New York. He ran record labels, hosted psychedelic trance events, and lived through the intensity of that scene. Why Music Is Medicine Matt believes music should be treated as medicine. He explains how playlists can align with the stages of a psychedelic journey—onset, climb, peak, and descent. He encourages people to listen with intention and to...
info_outlinePsychedelics Today
In this episode, Joe Moore sits down with Dr. Case Newsom, an emergency room physician in Denver and Medical Director for both Zendo Project and Stadium Medical. They explore how psychedelic harm reduction is merging with event medicine at concerts, festivals, and large-scale gatherings. Dr. Newsom shares his path from osteopathic medical training to bridging emergency medicine with psychedelic peer support. He explains how the Zendo Project has expanded beyond Burning Man, and why collaboration with medical teams matters. The discussion highlights new triage protocols, cultural shifts in...
info_outlinePsychedelics Today
In this episode, Joe Moore is joined by Kat Murti, Executive Director of Students for Sensible Drug Policy (SSDP), the largest youth-led network working to end the war on drugs. SSDP organizes at the campus, local, state, federal, and international levels, with more than 100 chapters across the U.S. and sister organizations worldwide. Kat shares her personal journey into drug policy reform, from witnessing DEA raids on AIDS patients in the 1990s to fighting for civil liberties as a student at UC Berkeley. She explains how SSDP empowers young people to challenge outdated laws and promote...
info_outlinePsychedelics Today
In this episode, Joe Moore is joined by Mareesa Stertz and Tania Abdul, the visionaries behind Sphinx Gate, one of Burning Man 2025’s most ambitious and mythic art installations. Inspired by The NeverEnding Story, Sphinx Gate features two towering 34-foot sphinxes and a fully immersive, transformative art experience designed to help participants gain a deeper understanding of themselves. The trio explores how art and play can catalyze personal and collective transformation—without the need for psychedelics—by helping people reframe inner challenges as quests for growth. They discuss the...
info_outlinePsychedelics Today
In this episode of Psychedelics Today, Joe Moore sits down with Chad Charles — educator, mentor, and practitioner specializing in 5-MeO-DMT therapy. Chad shares his decade-long journey working with 5-MeO-DMT, emphasizing the importance of: Practitioner training and mentorship Personalized, therapeutic alliances The nuanced understanding of dissociative states Ethics in standardized clinical dosing A trauma-informed approach to psychedelic care He also introduces his upcoming research project, analyzing 500+ one-on-one sessions to illuminate best practices and ethical frameworks...
info_outlinePsychedelics Today
In this episode of Psychedelics Today, Joe Moore sits down with Alan Davis, Associate Professor at Ohio State University, to explore the evolving landscape of Ibogaine research and its therapeutic potential. Alan offers a deep dive into the Iboga Patient Survey, a groundbreaking initiative collecting real-world data on the safety and efficacy of Ibogaine—particularly for those struggling with substance use disorders and mental health challenges. The conversation sheds light on the need for rigorous, community-informed research that could pave the way toward FDA approval and increased access...
info_outlinePsychedelics Today
In this engaging episode of the Psychedelics Today podcast, host Joe Moore sits down with Karina Bashir, an attorney working at the intersection of law, business ethics, and psychedelics. Karina, of counsel with Antithesis Law and an active member of the psychedelic community, shares her unique journey from human rights advocacy into the evolving field of psychedelic law. The conversation explores her presentation at Harvard on psychedelics and monotheistic religions, and her efforts to bridge the gap between Islamic communities and psychedelic-assisted healing. She discusses the legal...
info_outlinePsychedelics Today
In this deeply important episode of Psychedelics Today, Joe Moore is joined by Kristen Nash, MPH, and returning guest Erica Siegel, LCSW, for a nuanced conversation about risk reduction, harm prevention, and ethical education in the psychedelic space. Kristen shares the powerful and heartbreaking story of losing her 21-year-old son after a tragic psychedelic-related incident. Motivated by this loss and her background in public health, she founded the Coalition for Psychedelic Safety and Education and launched the Before You Trip campaign—an educational initiative piloting in Colorado aimed...
info_outlinePsychedelics Today
In this episode, Joe Moore speaks with award-winning science journalist Erica Rex about her personal experience participating in psychedelic research, her upcoming book Seeing What Is There: My Search for Sanity in the Psychedelic Era, and the complex story behind the recently published Religious Leader Psilocybin Study from Johns Hopkins and NYU. They examine: Erica's firsthand experience as a participant in the original 2012 study that helped launch Roland Griffiths’ prominence in psychedelic science. The goals and outcomes of the Religious Leader Study, which sought to explore how...
info_outlinePsychedelics Today
In this expansive episode of Psychedelics Today, Joe Moore sits down with author and cultural theorist Daniel Pinchbeck to explore the evolving—and increasingly contested—role of psychedelics in society. From the hopeful spirit of transformation that animated earlier psychedelic movements to the sobering reality of biotech, branding, and political entanglement, Daniel offers a candid diagnosis of where we are—and where we might be headed. Reflecting on Psychedelic Science 2025, Daniel discusses the event’s stark shift toward commercialization and industry influence. He contrasts this...
info_outlineIn this episode, Joe interviews Joost Breeksema from the Netherlands to talk about the Interdisciplinary Conference on Psychedelic Research. In the show they cover topics on ICPR 2020, and the importance of accessibility.
3 Key Points:
- The Interdisciplinary Conference on Psychedelic Research takes place April 24-26, 2020 in the Netherlands.
- It's important to acknowledge the indigenous, ethical, and political dimensions to psychedelic use at conferences.
- Although this conference will be catered toward mainstream science and research, personal experiences and stories are important too.
Support the show
- Patreon
- Leave us a review on iTunes
- Share us with your friends – favorite podcast, etc
- Join our Facebook group - Psychedelics Today group – Find the others and create community.
Navigating Psychedelics
Show Notes
About Joost
- Joost is a part of the OPEN Foundation
- ICPR is a huge conference
- Nobody before was doing research on psychedelics in the Netherlands
- William James work sparked Joost’s interest in psychedelics
ICPR
- Starting with the OPEN Foundation, the conference has been very scientific
- It is interdisciplinary, but also taken very seriously
- This field is so broad, you could really never get bored
- Wade Davis, Alicia Danforth, Matt Johnson and more will be speaking at the conference
- There will be over 80 speakers
- Joost expects it to be a pretty international conference, half local, and half from abroad
- Psychiatrists are usually short on time, and they like things compressed more
- It's really easy and cheap to grow psilocybin as mushrooms or truffles
- Even in Mexico, they need to use GMP Psilocybin
Accessibility
- “If this is going to be the treatment, how are we going to help people afford it?” - Joe
- There is some tricky stuff happening, companies trying to patent different parts of psilocybin to use it for therapeutic use
- Ketamine has been off patent for years, but you can develop a new route of administration, patent that, and make a ton of money
- Spravato is making it to the UK
Conference Themes
- Joost is both excited and scared that they are bringing indigenous practitioners to the conference
- It's important to acknowledge the indigenous, ethical, and political dimensions to psychedelic use
- Talking about concepts and approaches to healing is going to be an important aspect
- The goal would be to do research with the indigenous communities to be able to address the needs of psychedelic use
- There are also a few neuroimaging people coming
- For mainstream scientists, the conference has to be as close to a scientific conference as possible, they may be turned off to the cultural aspects of psychedelics
- It's the conservative nature of psychedelia
- Joost also says that although the scientific research is important, it is really cool to hear the personal experiences
- Joe brings up a previous episode of a therapist and patient from the MDMA trials
- Stories are much more convincing than just data
- People’s experience with psychedelics may be completely different from each other
- It's important to share the bad stories with the good stories
- If we don't share the stories and data and research, then we can never learn
- Joe hopes that there will be a growth of citizen science in the near future
Links
About Joost
Joost Breeksema is a part of the OPEN Foundation, which from it came the Interdisciplinary Conference on Psychedelic Research. His current research focuses on the experiences of patients that are undergoing therapy assisted by psychedelic substances. His aim is to better understand psychological mechanisms of action/change, to tease out salient themes, and finally to learn about what works and what does not work in psychedelic-assisted psychotherapy.

